«Degenerative Nerve

Below is an extended Degenerative Nerve patents listing. Click here to return to the Degenerative Nerve main in depth entry.

Patents :
US Patent No.	Title
4902680	Treating central nervous system diseases
5831050	Morphogen cell surface receptor
5854071	OP-3- induced morphongenesis
5861479	Morphogen cell surface receptor
5863738	Methods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptides
5935852	DNA molecules encoding mammalian cerberus-like proteins
5952011	Human transglutaminases
5955290	Assay systems using the CNTF signal transduction pathway
5968752	Method for identifying an OP-1 analog which binds an ALK-1 receptor
5972953	Brain cell protective agent
6025333	Treatment of CNS tumors with metalloprotease inhibitors
5684133	Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions
5652337	OP-3-induced morphogenesis
5652118	Nucleic acid encoding a novel morphogenic protein, OP-3
5017470	Method of diagnosing alzheimer's disease and senile dementia
5118505	Combination preparation for the treatment of nerve cell and nerve fibre diseases and injury
5180820	Brain-derived neurotrophic factor
5229500	Brain derived neurotrophic factor
5250414	Diagnostic methods using neurite growth regulatory factors
5332672	Prevention of ES cell differentiation by ciliary neurotrophic factor
5438121	Brain derived neurotrophic factor
5453361	Method for producing biologically active human brain derived neurotrophic factor
5455254	Substituted benzofuranylpiperidine as a nootropic agent
5514579	Human transglutaminases
6066658	Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentiation induction factor action
6093547	Morphogen cell surface receptor and screening for morphogen analogs
6887695	Transglutaminase ztg2
6914056	Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
6933276	Methods of treating peripheral neuropathies using neurotrophin-3
6960559	Neurite growth regulatory factors
7041474	Nucleic acid encoding human tango 509
7067260	Methods of identifying morphogen receptor-binding analogs
7098302	Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
7169783	(+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion
7196056	Protein-induced morphogenesis of kidney tissue
7385036	Human tango 509 polypeptides
6632618	Morphogenic protein-specific cell surface receptors and uses therefor
6602687	DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded thereby
6565843	Protein-induced tissue morphogenesis
6103232	Neurite growth regulatory factors
6147084	Brain cell protective agent
6153583	OP-3 induced morphogenesis
6177438	Morphinan derivatives and pharmaceutical use thereof
6211146	60A protein-induced morphogenesis
6242471	Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentiation induction factor action
6273598	Computer system and methods for producing morphogen analogs of human OP-1
6391905	Condensed 4,5,6,7-tetrahydrobenzo[C]thiopenes as enhancer for cell differentiation induction factor action
6489351	Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentation induction factor action
6531445	Protein-induced morphogenesis in liver tissue
7425334	Methods of making antibodies that bind Nogo

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.